David Boyer from Retina-Vitreous Associates Medical Group: Exploring Combination Therapy in Ophthalmology

There are many areas of medicine where treatments are being combined in hopes of finding better outcomes for patients. Early studies are being done to see if a new combination can help patients with certain eye conditions.

David Boyer, MD, from the Retina-Vitreous Associates Medical Group in California discussed the results of a recent phase I trial involving Eylea and other medications for the treatment of age related macular degeneration and diabetic macular edema. Boyer presented the results of the trial at the annual meeting of the American Society of Retina Specialists in San Francisco as part of a larger discussion on combination medications.